Sort
78,016 grants matching “breast cancer”
(PQA4) GPS exposure to environments & relations with biomarkers of cancer risk
$733,604Jacqueline Kerr · University Of California, San Diego · R01 · FY2013 · CA
New Therapies to Restore Vascular Integrity During Sepsis
$733,546Andrew Scott Weyrich · University Of Utah · R01 · FY2017 · HL
Determinants of Breast Cancer Survival
$733,517University Of Texas Md Anderson Can Ctr · R01 · FY2003 · CA
Effect and Mechanism of Acupuncture for Cancer-related Cognitive Impairment (ENHANCE)
$733,456Jun J Mao · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Project 3: Integration of mammographic AI, clinical, and genomics information to improve breast cancer subtype- specific risk-based screening and prevention
$733,345Vignesh A Arasu · University Of California, San Francisco · P01 · FY2025 · CA
Cognition In Older Breast Cancer Survivors: Treatment Exposure, APOE, & Smoking
$733,270Tim Alan Ahles · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA
Prospective Trial of a Linguistically and Culturally Appropriate Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Diverse Cancer Patients
$733,228Jada Gabrielle Hamilton · Sloan-Kettering Inst Can Research · U01 · FY2021 · CA
Using a SMART design to evaluate remotely delivered, community-aligned weight loss interventions among breast cancer survivors
$733,168Heather A Greenlee · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Epidemiologic Field Studies
$733,103Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
Mechanism of Action of a Novel Golgi-Targeted Anti-Cancer Agent
$733,096Seth J Field · Case Western Reserve University · R01 · FY2021 · CA
Activating gasdermin pores to induce pyroptosis and stimulate anti-tumor immunity
$733,069Hao Wu · Boston Children'S Hospital · R01 · FY2024 · CA
Activating gasdermin pores to induce pyroptosis and stimulate anti-tumor immunity
$733,069Hao Wu · Boston Children'S Hospital · R01 · FY2025 · CA
DULUTH COMMUNITY CLINCIAL ONCOLOGY PROGRAM
$732,989Duluth Clinic, Ltd. · U10 · FY2002 · CA
Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial
$732,980Ting Bao · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials
$732,973Andre Rogatko · Cedars-Sinai Medical Center · U01 · FY2018 · CA
Randomized Phase II Trial of Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women with Hormone Receptor Positive Advanced Breast Cancer (FastER)
$732,901Tracy E Crane · University Of Miami School Of Medicine · R01 · FY2024 · CA
Monitoring tumor subclonal heterogeneity over time and space
$732,893Gabor T Marth · University Of Utah · U24 · FY2019 · CA
Quantitative Optical Imaging and Spectroscopy of Biological tissue
$732,791Amir H Gandjbakhche · Child Health And Human Development · Z01 · FY2007 · HD
HORMONE REPLACEMENT THERAPY AND BREAST CANCER
$732,607Dartmouth College · R01 · FY2002 · CA
Identification of Genes and DNA Methylation Markers for Lung Cancer Risk by Integrating Multi-omics Data
$732,586Qiuyin Cai · Vanderbilt University Medical Center · R01 · FY2021 · CA
Enhanced Pain Coping in Cancer (EPIC)
$732,536Jun J Mao · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Fatigue, depression, and inflammation in cancer survivors: A prospective study
$732,532Janice K Kiecolt-Glaser · Ohio State University · R01 · FY2012 · CA
Rewiring of regulatory networks in breast cancer by transcription factor isoforms
$732,505Marc Vidal · Dana-Farber Cancer Inst · U01 · FY2022 · CA
(3 of 3) MMC, VICC & TSU: Partners in Eliminating Cancer Disparities
$732,446Margaret M Whalen · Tennessee State University · U54 · FY2021 · CA
AKT as a Biomarker of Ovarian Cancer Progression and a Target for Therapy
$732,444Joseph Robert Testa · Fox Chase Cancer Center · P50 · FY2007 · CA